News

Sumatriptan may finally relieve French headaches

BMJ 1994; 309 doi: https://doi.org/10.1136/bmj.309.6954.561 (Published 03 September 1994) Cite this as: BMJ 1994;309:561
  1. A Dorozynski

    Four years after Glaxo made its first application to market sumatriptan in France the antimigraine drug is still not available in pharmacies - at least, not legally. But an agreement between Glaxo's French subsidiary and the French ministry of health and social affairs may enable doctors to prescribe the drug and some patients to be partly reimbursed for it through the social security system. The problem is money. Glaxo originally wanted to charge Fr170 (about £20) for an injectable dose and Fr90 (£10.50) …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe